Maurice Blackburn has persuaded a judge to lift a temporary injunction that blocked the law firm from going ahead with plans to unveil a replica of the iconic New York statue, Fearless Girl, at Melbourne’s Federation Square for International Women’s Day.
Global insurer Jardine Lloyd Thompson has won access to the identities of local councils suing it in a NSW class action brought by Quinn Emanuel alleging the broker charged the councils excessive premiums.
Media organisations ABC and Fairfax have argued that a judge’s definition of espionage was “artificially narrow” when striking out their truth defence to a defamation case brought by Chinese philanthropist Dr Chau Chak Wing.
The Federal Government failed to read public submissions in approving a “flawed” assessment of a project supplying Adani’s controversial Carmichael coal mine with over 12.5 billion litres of water, an environmental group has told a court.
Gladstone Ports has won access to draft expert reports prepared by Clyde & Co in its $100 million class action against the Queensland government owned organisation, with a judge ruling the documents were not privileged despite their not being used in the case.
Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic pharmaceutical companies, whch argued Neurim had purposely delayed the application to gain an unfair advantage in its infringement suit.
A judge has reprimanded CIMIC Group’s preparations to defend a class action against it, saying a late attempt to file critical evidence was a sign something “pretty horrible” had gone on behind the scenes.
Liberal Democrat Senator David Leyonhjelm has lost his challenge to a ruling that denied his request for speedy dismissal of a defamation lawsuit by Greens Senator Sarah Hanson-Young on the grounds of Parliamentary privilege.
A judge has ruled for investors in a class action alleging they sank $12.3 million into a sports trading scam masterminded by convicted conman Peter Foster, saying they were entitled to recover their misappropriated money from the “notorious confidence trickster”.
Pharmaceutical giant Allergan has streamlined its trade mark case against Self Care Corporation, which makes products marketed as Botox alternatives.